Make your money go further for just 25p per day

AIM IHT

Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest

Mulberry tree

Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full acquisition. Read on for our thoughts on this and other updates here.


Fusion Antibodies: results underwhelm

Fusion Antibodies (LON: FAB), specialists in pre-clinical antibody discovery, for both therapeutic drug and diagnostic applications, underwhelmed with its interim results for the six months ending 30 September 2020, at least for a business with its high rating – the current market capitalisation is £29m.

Revenues rose 8.5% of £1.90m with losses remaining stable at £0.47m.

They expanded their R&D programme in the period by 50% to £271k to include a COVID-19 target…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Advanced Medical Solutions

Merger of equals | Exciting new arrival

10/01/2024 · Company Insights

2024 has started much as 2023 finished, with corporate activity on AIM that is likely to see…


Looking good | Hard to Judge | As flat as it gets

21/09/2023 · Company Insights

News covered here includes fabulous interim results from a supplier of colour cosmetics, whose shares have…


More on Argentex Group PLC

Episode 4 of the Investor’s Champion Podcast

03/02/2024 · Podcasts

In this episode of the Investor’s Champion Podcast, Chris and Lee run through key news from…


Bonkers Bargains: new management offers promise

30/01/2024 · Company Insights

Even in the most challenging of markets this business still generated significant profits and continued to pay…


More on Frasers Group

Has Nike been caught flat-footed?

05/01/2024 · Portfolio

Our portfolio company covered here dominates the market for athletic footwear, but is it the best…


Bonkers Bargain Mulberry still looks interesting

28/06/2023 · Company Insights

Having experienced a dramatic rise and fall over the past decade, Mulberry faces an uncertain future.…


More on Fusion Antibodies PLC

Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest

20/11/2020 · Company Insights

Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…


Coronavirus impact: 28 April - soaring share prices from this little lot

28/04/2020 · Company Insights

Announcements included an update from from Burford Capital, which saw its shares bounce strongly, but we still…


More Company Insights

Resilience in animal healthcare

Utter gobbledygook | Tough to value

When boring is best

Sign-up to our free email updates

SIGN UP